X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (214) 214
male (161) 161
index medicus (152) 152
endocrinology & metabolism (130) 130
female (130) 130
middle aged (116) 116
diabetes (104) 104
type 2 diabetes (102) 102
aged (96) 96
diabetes mellitus, type 2 - drug therapy (77) 77
diabetes mellitus (73) 73
animals (69) 69
insulin (67) 67
glucose (66) 66
adult (59) 59
japan (48) 48
hypoglycemic agents - therapeutic use (47) 47
treatment outcome (46) 46
type 2 diabetes mellitus (42) 42
analysis (38) 38
diabetes mellitus, type 2 - blood (37) 37
hemoglobin (37) 37
patients (37) 37
mice (34) 34
articles (33) 33
hypoglycemia (33) 33
internal medicine (32) 32
glycosylated hemoglobin (31) 31
medicine, general & internal (31) 31
diabetes mellitus, type 2 - genetics (30) 30
original (30) 30
hypoglycemic agents - adverse effects (28) 28
insulin resistance (28) 28
research (28) 28
therapy (28) 28
care and treatment (27) 27
glycemic control (27) 27
safety (27) 27
original article (26) 26
pharmacology & pharmacy (26) 26
asian continental ancestry group (25) 25
clinical trials (25) 25
hyperglycemia (25) 25
hypoglycemic agents - administration & dosage (25) 25
risk factors (25) 25
blood glucose - metabolism (24) 24
dextrose (24) 24
diabetes therapy (24) 24
genetic aspects (24) 24
metabolism (24) 24
time factors (24) 24
clinical science and care (23) 23
double-blind method (23) 23
endocrinology (23) 23
diabetes mellitus, type 2 - complications (22) 22
mellitus (22) 22
pioglitazone (22) 22
studies (22) 22
dose-response relationship, drug (21) 21
double-blind (21) 21
medical research (21) 21
medicine & public health (21) 21
rats (21) 21
blood glucose - drug effects (20) 20
clinical trial (20) 20
diabetes mellitus, type 2 - metabolism (20) 20
dipeptidyl peptidase-4 inhibitor (20) 20
hypoglycemic agents (20) 20
information storage (20) 20
information storage based on relative movement between recordcarrier and transducer (20) 20
medicine, research & experimental (20) 20
metformin (20) 20
physics (20) 20
body mass index (19) 19
drug therapy, combination (19) 19
health aspects (19) 19
insulin secretion (19) 19
obesity (19) 19
case report (18) 18
genetic predisposition to disease (18) 18
glycated hemoglobin a - metabolism (18) 18
insulin - metabolism (18) 18
medicine, experimental (18) 18
body weight (17) 17
gene expression (17) 17
glucagon-like peptide-1 (17) 17
glycated hemoglobin a - analysis (17) 17
japanese patients (17) 17
liraglutide (17) 17
medicine (17) 17
atherosclerosis (16) 16
efficacy (16) 16
multidisciplinary sciences (16) 16
risk (16) 16
secretion (16) 16
sodium (16) 16
uracil - analogs & derivatives (16) 16
aged, 80 and over (15) 15
anagliptin (15) 15
apoptosis (15) 15
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Diabetes Investigation, ISSN 2040-1116, 09/2019
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9675, pp. 1607 - 1614
Journal Article
Journal of diabetes investigation, 08/2019
The intracellular GLP-1 signalling pathway, which involves cAMP, Epac2, PKA, and K channels, has been widely accepted as a common mechanism of GLP-1 stimulated... 
Journal Article
Gastroenterology, ISSN 0016-5085, 09/2019, Volume 157, Issue 3, pp. 898 - 899
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 10/2019, Volume 21, Issue 10, pp. 2284 - 2293
To assess the efficacy and safety of once-daily ipragliflozin 50 mg versus placebo in Japanese people with type 1 diabetes mellitus (T1DM) inadequately... 
clinical trial | antidiabetic drug | type 1 diabetes | insulin therapy | SGLT2 inhibitor | phase III study | METABOLIC SYNDROME | GLYCEMIC CONTROL | ASP1941 | ENDOCRINOLOGY & METABOLISM | BODY-MASS INDEX | COTRANSPORTER 2 INHIBITOR | Diabetes mellitus | Body weight | Ketoacidosis | Hemoglobin | Diabetes mellitus (insulin dependent) | Diabetes | Safety | Hypoglycemia | Insulin | Original
Journal Article
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2016, Volume 38, Issue 1, pp. 66 - 88.e20
Abstract Purpose To evaluate the influence of renal function on the efficacy and safety of the sodium glucose cotransporter 2 inhibitor luseogliflozin (TS-071)... 
Internal Medicine | Medical Education | type 2 diabetes mellitus | sodium glucose cotransporter 2 inhibitor | luseogliflozin | glomerular filtration rate | Japanese | renal impairment | Key words glomerular filtration rate | LONG-TERM | MONOTHERAPY | SGLT2 INHIBITOR | PHARMACODYNAMICS | PHARMACOKINETICS | CANAGLIFLOZIN | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | COMPLICATIONS | CHRONIC KIDNEY-DISEASE | sodium glucose co-transporter 2 inhibitor | EMPAGLIFLOZIN | Body Weight | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | Renal Insufficiency - physiopathology | Sorbitol - analogs & derivatives | Adult | Female | Renal Insufficiency - complications | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Glomerular Filtration Rate | Blood Glucose - analysis | Double-Blind Method | Drug Administration Schedule | Japan | Treatment Outcome | Diabetes Mellitus, Type 2 - blood | Sorbitol - adverse effects | Aged | Sodium-Glucose Transport Proteins - antagonists & inhibitors | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Sorbitol - therapeutic use | Type 2 diabetes | Medical colleges | Glucose | Dextrose | Studies | Confidence intervals | Heart attacks | Statistical analysis | Rodents | Mortality | Clinical medicine | Diabetes | Kidney diseases
Journal Article
Journal Article